تداخل‌های دارویی
Exenatide injectable + Insulin degludec-liraglutide
شدت: شدید
Exenatide injectable and Insulin degludec-liraglutide: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
معنای این تداخل به زبان ساده
Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
چرا رخ می‌دهد
Therapeutic duplication of GLP-1 receptor agonism with additive glucose-lowering effects.
اقدام لازم
Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Exenatide injectable و Insulin degludec-liraglutide، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Insulin degludec-liraglutide
پرسش‌های متداول
Can I take Exenatide injectable with Insulin degludec-liraglutide?
MediHelp rates the interaction as major. Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
How serious is the interaction between Exenatide injectable and Insulin degludec-liraglutide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
What other medicines interact with Insulin degludec-liraglutide?
MediHelp also lists interactions of Insulin degludec-liraglutide with, for example, Albiglutide, Chlorpropamide, Clozapine. The full list is on the Insulin degludec-liraglutide page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
